Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer.

Autor: Luhn P; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Chui SY; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Hsieh AF; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Yi J; Genesis Research Group, 5 Marine View Plaza, Hoboken, NJ 07030, USA., Mecke A; F. Hoffmann-La Roche, 4 Oncology, Grenzacherstrasse 124, 4070 Basel, Switzerland., Bajaj PS; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Hasnain W; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Falgas A; F. Hoffmann-La Roche, 4 Oncology, Grenzacherstrasse 124, 4070 Basel, Switzerland., Ton TG; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Kurian AW; Departments of Medicine (Oncology) & of Health Research & Policy, Women's Clinical Cancer Genetics Program, Stanford University School of Medicine HRP Redwood Building, Room T254A, 150 Governor's Lane, Stanford, CA 94305, USA.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2019 Oct; Vol. 8 (14), pp. 1173-1185. Date of Electronic Publication: 2019 Aug 09.

Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction.

Autor: Dreyer RP; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted. rachel.dreyer@yale.edu., Ranasinghe I; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Wang Y; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Dharmarajan K; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Murugiah K; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Nuti SV; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Hsieh AF; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Spertus JA; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Krumholz HM; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted.

Publikováno v: Circulation [Circulation] 2015 Jul 21; Vol. 132 (3), pp. 158-66. Date of Electronic Publication: 2015 Jun 17.

Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study.

Autor: Ranasinghe I; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Wang Y; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Dharmarajan K; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America; Division of Cardiology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America., Hsieh AF; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Bernheim SM; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America., Krumholz HM; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, United States of America; Division of Cardiology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America; The Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, United States of America; Health Policy and Management, School of Public Health, Yale University, New Haven, Connecticut, United States of America.

Publikováno v: PLoS medicine [PLoS Med] 2014 Sep 30; Vol. 11 (9), pp. e1001737. Date of Electronic Publication: 2014 Sep 30 (Print Publication: 2014).

Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions.

Autor: Dharmarajan K; Division of Cardiology, Department of Internal Medicine, Columbia University Medical Center, 630 West 168th Street, Box 93, PH 10-203, New York, NY 10032, USA., Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Suter LG, Bernheim SM, Drye EE, Krumholz HM

Publikováno v: BMJ (Clinical research ed.) [BMJ] 2013 Nov 20; Vol. 347, pp. f6571. Date of Electronic Publication: 2013 Nov 20.